Research Guide
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide — a 15 amino acid sequence derived from a portion of human gastric juice protein. It has been studied extensively in animal models and in vitro settings since the early 1990s, with research focusing on its effects on tissue repair, gut integrity, and tendon healing pathways.
The compound is classified as an RUO (Research Use Only) peptide, meaning it is sold strictly for laboratory and scientific study contexts. It has not been approved by the FDA for human therapeutic use.
TB-500 is a synthetic analog of Thymosin Beta-4, a naturally occurring 43 amino acid peptide found throughout the body. The TB-500 fragment — specifically the Ac-SDKP sequence — has been studied for its role in actin sequestration, cellular migration, and angiogenesis. Research contexts include wound healing models and musculoskeletal tissue studies.
In research settings, BPC-157 and TB-500 are frequently sourced as a blend because their proposed mechanisms are considered complementary. BPC-157 research tends to focus on localized tissue effects and gut-brain signaling pathways, while TB-500 research emphasizes systemic cellular migration and angiogenic signaling. Researchers studying multi-pathway repair models often find value in evaluating them together within a single protocol.
For researchers sourcing BPC-157 and TB-500, purity documentation is critical. HPLC purity above 98% and mass spectrometry identity confirmation are the baseline standards. COA data — not blanket manufacturer claims — are what distinguish credible research suppliers from commodity vendors.
At Plato Peptides, every BPC-157/TB-500 blend ships with a Certificate of Analysis from an independent third-party laboratory. Purity is verified per batch, not per catalog listing.